The Chosun Ilbo on MSN
Pfizer Sues Novo Nordisk, Metsera in Obesity Drug Bid
The acquisition battle between global pharmaceutical giants Pfizer and Novo Nordisk over the bio company Metsera is ...
Novo Nordisk made a surprise bid for Metsera to boost its weight-loss market lead, trading at just 12x 2026 EPS. Read why NVO ...
Novo Nordisk and Pfizer are showing some desperation in their gloves-off tussle for the obesity-drug assets of Metsera.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback